Fingerprint
Dive into the research topics of 'Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
Ernst-Wilhelm Radue, William H Stuart, Peter A Calabresi, Christian Confavreux, Steven L Galetta, Richard A Rudick, Fred D Lublin, Bianca Weinstock-Guttman, Daniel R Wynn, Elizabeth Fisher, Athina Papadopoulou, Frances Lynn, Michael A Panzara, Alfred W Sandrock, SENTINEL Investigators, Per Soelberg Sørensen, Morten Bjørn Blinkenberg